Rentschler Biotechnology is a global full-service contractor with more than 30 years of experience in developing, manufacturing, and approvals of bio-pharmaceuticals.
- The company’s new production facility for monoclonal antibodies has been designed to cater for an annual capacity of up to 10 products with a maximum of 24 1,000 liter charges.
The goal of the project was to achieve higher flexibility and lower manufacturing costs.
- Rentschler was interested in redesigning the production facilities to allow for manufacturing a broader range of products.
- Upgrates to the SAP system and other IT components were also required to be planned and implemented.